Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells
暂无分享,去创建一个
Xiao‐Kang Li | M. Fujino | Hirotake Tsukamoto | K. Hasumi | H. Hirano | Yifang Shui | Xin Hu | Wen-zhi Guo | F. Ijima
[1] Xiao‐Kang Li,et al. β-glucan from Aureobasidium pullulans augments the anti-tumor immune responses through activated tumor-associated dendritic cells. , 2021, International immunopharmacology.
[2] F. Ginhoux,et al. TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses , 2021, Nature Communications.
[3] Jarred M. Whitlock,et al. Flagging fusion: Phosphatidylserine signaling in cell–cell fusion , 2021, The Journal of biological chemistry.
[4] Allon M. Klein,et al. Tumor-infiltrating dendritic cell states are conserved across solid human cancers , 2020, The Journal of experimental medicine.
[5] C. Sautès-Fridman,et al. Dendritic cells in the tumor microenvironment: prognostic and theranostic impact. , 2020, Seminars in immunology.
[6] Xiaojun Liu,et al. Tim-4 in Health and Disease: Friend or Foe? , 2020, Frontiers in Immunology.
[7] Leaf Huang,et al. Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies , 2020, Theranostics.
[8] Yongling Ning,et al. Key genes and pathways in tumor‐educated dendritic cells by bioinformatical analysis , 2020, Microbiology and immunology.
[9] Fiorella Kotsias,et al. Antigen processing and presentation. , 2019, International review of cell and molecular biology.
[10] J. Bluestone,et al. Revisiting IL-2: Biology and therapeutic prospects , 2018, Science Immunology.
[11] J. Rossjohn,et al. Phospholipid signaling in innate immune cells. , 2018, The Journal of clinical investigation.
[12] Jian-guo Li,et al. CD80 and CD86 knockdown in dendritic cells regulates Th1/Th2 cytokine production in asthmatic mice. , 2016, Experimental and therapeutic medicine.
[13] S. Senju,et al. IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age , 2015, Nature Communications.
[14] Taku Kambayashi,et al. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? , 2014, Nature Reviews Immunology.
[15] D. Vance,et al. The Concentration of Phosphatidylethanolamine in Mitochondria Can Modulate ATP Production and Glucose Metabolism in Mice , 2014, Diabetes.
[16] Pierre Validire,et al. Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. , 2014, Cancer research.
[17] C. Sakamoto,et al. Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells , 2013, Immunology and cell biology.
[18] T. Satoh,et al. Emulsified Phosphatidylserine, Simple and Effective Peptide Carrier for Induction of Potent Epitope-Specific T Cell Responses , 2013, PloS one.
[19] V. Kuchroo,et al. IL-12 family cytokines: immunological playmakers , 2012, Nature Immunology.
[20] A. M. Rauwerdink,et al. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells , 2012, The Journal of experimental medicine.
[21] M. Wright,et al. Inflammatory mediators hold the key to dendritic cell suppression and tumor progression. , 2011, Current medicinal chemistry.
[22] G. Kroemer,et al. Prognostic and predictive impact of intra- and peritumoral immune infiltrates. , 2011, Cancer research.
[23] Xianqun Fan,et al. Efficient identification of phosphatidylserine-binding proteins by ORF phage display. , 2009, Biochemical and biophysical research communications.
[24] J. Vance,et al. Defining the Importance of Phosphatidylserine Synthase-1 (PSS1) , 2008, Journal of Biological Chemistry.
[25] G. Freeman,et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. , 2007, Immunity.
[26] J. Gregg,et al. Exposure of Myeloid Dendritic Cells to Exogenous or Endogenous IL-10 during Maturation Determines Their Longevity1 , 2007, The Journal of Immunology.
[27] D. Smrz,et al. Non-apoptotic Phosphatidylserine Externalization Induced by Engagement of Glycosylphosphatidylinositol-anchored Proteins* , 2007, Journal of Biological Chemistry.
[28] A. Mackensen,et al. Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. , 2006, Blood.
[29] H-Z Shi,et al. CD28/CTLA‐4–CD80/CD86 and ICOS–B7RP‐1 costimulatory pathway in bronchial asthma , 2006, Allergy.
[30] M. Wright,et al. Dendritic cells: activation and maturation--applications for cancer immunotherapy. , 2005, Current medicinal chemistry.
[31] Mitsuhiro Nishida,et al. An Increased Adjuvanticity of Liposomes by the Inclusion of Phosphatidylserine in Immunization with Surface-Coupled Liposomal Antigen , 2005, International Archives of Allergy and Immunology.
[32] N. Romani,et al. High Level IL-12 Product ion by Murine Dendrit ic Cells : Upregulation via MHC Class II and CD 40 Molecules and Downregulat ion by IL-4 and IL-10 By , 2003 .
[33] J. Keenan,et al. Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. , 2002, The Journal of family practice.
[34] P. Hwu,et al. CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cells. , 2002, Journal of immunological methods.
[35] Ira Mellman,et al. Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.
[36] Richard A. Flavell,et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.
[37] G. Schuler,et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590] , 1996, The Journal of experimental medicine.
[38] A. Lanzavecchia,et al. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.
[39] J. Berzofsky,et al. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. , 1996, Cellular immunology.
[40] J. Faivre,et al. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[41] V. Fadok,et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.